Survival without toxicity for cisplatin plus pemetrexed versus cisplatin plus gemcitabine in chemonaïve patients with advanced non-small cell lung cancer: a risk-benefit analysis of a large phase III study.


SCAGLIOTTI G., PARK K., PATIL S., ROLSKI J., Goksel T. , MARTINS R., ...Daha Fazla

European journal of cancer (Oxford, England : 1990), cilt.45, ss.2298-303, 2009 (SCI Expanded İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 45
  • Basım Tarihi: 2009
  • Doi Numarası: 10.1016/j.ejca.2009.04.033
  • Dergi Adı: European journal of cancer (Oxford, England : 1990)
  • Sayfa Sayıları: ss.2298-303